Timothy Cowper

Former Director & Finance Director at Bioventix Plc

Timothy Cowper

Timothy Cowper

Former Director & Finance Director at Bioventix Plc

Overview
RelSci Relationships

126

Number of Boards

3

Birthday

1968

Age

50

Relationships
RelSci Relationships are individuals Timothy Cowper likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Bioventix Plc

Relationship likelihood: Strong

Chief Executive Officer at F2G Ltd.

Relationship likelihood: Strong

Former Finance Director at Bioventix Plc

Relationship likelihood: Strong

Partner at Novastar Ventures Ltd.

Relationship likelihood: Strong

Chief Business Officer at DNA Electronics Ltd.

Relationship likelihood: Average

Company Secretary at Consort Medical Plc

Relationship likelihood: Average

Senior Vice President Pharmaceutical Quality Operations at Vernalis Plc

Relationship likelihood: Average

Former Chief Executive Officer at Alpha Biologics Ltd.

Relationship likelihood: Average

Analyst at Cato BioVentures

Relationship likelihood: Average

Secretary at Clipper Ventures Plc

Relationship likelihood: Average

Paths to Timothy Cowper
Potential Connections via
Relationship Science
You
Timothy Cowper
Former Director & Finance Director at Bioventix Plc
Career History
Director & Finance Director
2010 - 2012

Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.

Financial Controller
Prior

Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.

Financial Controller
Prior

Realm Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the development of novel therapeutics for immunemediated diseases. It focusThe company was founded on April 21, 2006 and is headquartered in Malvern, PA.

Boards & Committees
Director
Current
Director
Current
Director & Finance Director
2010 - 2012

Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Timothy Cowper. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Timothy Cowper's profile does not indicate a business or promotional relationship of any kind between RelSci and Timothy Cowper.